The 5-lipoxygenase inhibitor zileuton confers neuroprotection against glutamate oxidative damage by inhibiting ferroptosis
Given its small molecular weight, -Arbutin, with its hydroxyphenyl head, can easily fit into the binding pocket of both hTYR and mTYR
If deprescribing is justified, prescribers, pharmacists, and pharmacy technicians need a plan of action for each medication (i.e., whether to abruptly stop or if gradual dose reduction (GDR) is necessary)
Head-to-Head Clinical Trial Results For years, comparing Tirzepatide and Semaglutide required extrapolating from separate trials with different patient populations and study designs
Stop dreaming about change and start creating it with our help today
In silico approach confirms a reduction of late-INa by empagliflozin demonstrating that SGLT2 inhibitors may be the ligands for the cardiac sodium channel Nav1.5 isoform that drives late-INa (Philippaert et al., 2021)